Related Experiment Video
Updated: Oct 14, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Geehan Suleyman1, George J Alangaden2
1Infection Prevention and Control, Henry Ford Hospital, Wayne State University, 2799 West Grand Boulevard, CFP Suite 317, Detroit, MI 48202, USA.
Abstract:
Invasive fungal infections are an important cause of morbidity and mortality in hospitalized patients and in the immunocompromised population. This article reviews the current epidemiology of nosocomial fungal infections in adult patients, with an emphasis on invasive candidiasis (IC) and invasive aspergillosis (IA). Included are descriptions of nosocomial infections caused by Candida auris, an emerging pathogen, and IC- and IA-associated with coronavirus disease 2019. The characteristics and availability of newer nonculture-based tests for identification of nosocomial fungal pathogens are discussed. Recently published recommendations and guidelines for the control and prevention of these nosocomial fungal infections are summarized.
Insights
Nosocomial fungal infections, particularly invasive candidiasis and invasive aspergillosis, significantly impact hospitalized and immunocompromised patients. This review covers epidemiology, emerging pathogens like Candida auris, and new diagnostic tests for better control.
Area of Science:
- Infectious Diseases
- Medical Microbiology
- Hospital Epidemiology
Background:
- Invasive fungal infections (IFIs) are a major cause of illness and death in hospitals, especially in immunocompromised individuals.
- Nosocomial (hospital-acquired) fungal infections pose a significant clinical challenge.
- Key pathogens include Candida species and Aspergillus species.
Purpose of the Study:
- To review the current epidemiology of nosocomial fungal infections in adult patients.
- To focus on invasive candidiasis (IC) and invasive aspergillosis (IA).
- To discuss emerging pathogens and recent advancements in diagnostics and guidelines.
Main Methods:
- Literature review of current epidemiology.
- Focus on specific fungal pathogens and associated conditions.
- Discussion of nonculture-based diagnostic methods and recent guidelines.
Main Results:
- Invasive candidiasis and invasive aspergillosis are significant nosocomial infections.
- Candida auris is an emerging pathogen of concern.
- COVID-19 is associated with increased IC and IA.
- Newer nonculture-based tests offer improved identification.
- Updated guidelines provide strategies for prevention and control.
Conclusions:
- Understanding the epidemiology of nosocomial fungal infections is crucial for patient outcomes.
- Emerging pathogens and novel diagnostics require attention.
- Adherence to updated guidelines is essential for infection control.
More Related Videos
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Fungal Phylum Microsporidia

